Johnson & Johnson to Buy Remaining Stake in Crucell for €1.75 Billion (update)
11:48 AM | September 17, 2010 | Deepti Ramesh
Biopharmaceutical company Crucell (Leiden, Netherlands) says that it is in advanced negotiations with Johnson & Johnson (J&J; New Brunswick, NJ), for a potential public offer by J&J for all...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.